Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2Gynecologic 2Gastrointestinal 2CNS 2Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1Breast 1

Conditions

Lymphoma 4Sleep Initiation and Maintenance Disorders 2Multiple Myeloma 2Lymphoma, Follicular 2Glioblastoma 2Fatigue 2Anxiety Disorders 2Uterine Neoplasms 1Sleep Wake Disorders 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Oligodendroglioma 1Neoplasms 1Meningioma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1Glioma 1Generalized Anxiety Disorder 1Esophageal Neoplasms 1Depression 1Brain Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 35Rituximab 33venetoclax 24ibrutinib 14Vincristine 14Prednisone 14Doxorubicin 14Gemcitabine 13pembrolizumab 12fludarabine 12Bendamustine Hydrochloride 11Etoposide 10obinutuzumab 9Filgrastim 9Dexamethasone 9Bortezomib 9fludarabine phosphate 8Mycophenolic Acid 8Drug Therapy 8ofatumumab 7Whole-Body Irradiation 7Sirolimus 7Peripheral Blood Stem Cell Transplantation 7Methotrexate 7Busulfan 7Therapeutics 6Radiotherapy 6Mesna 6Lenalidomide 6Ipilimumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Cognitive Behavioral Therapy × Lymphoid × Clear all
NCT01929720 2017-04-05

FOCUS

Ohio State University Comprehensive Cancer Center

Phase NA Completed
33 enrolled
CNSGastrointestinalGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Anxiety Disorders, Depression, Esophageal Neoplasms, Fatigue, Glioblastoma, Sleep Initiation and Maintenance Disorders, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Pain, Pancreatic Neoplasms, Sleep Wake Disorders, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡